Nanomedicine in treatment of breast cancer – A challenge to conventional therapy
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Amongst the various types of cancer, breast cancer is a highly heterogeneous disease and known as the leading cause of death among women globally. The extensive interdisciplinary investigation in nanotechnology and cancer biomedical research has been evolved over the years for its effective treatment. However, the advent of chemotherapeutic resistance in breast cancer is one of the major confront researchers are facing in achieving successful chemotherapy. Research in the area of cancer nanotechnology over the years have now been revolutionized through the development of smart polymers, lipids, inorganic materials and eventually their surface-engineering with targeting ligands. Moreover, nanotechnology further extended and brings in the notice the new theranostic approach which combining the therapy and imaging simultaneously. Currently, research is being envisaged in the area of novel nano-pharmaceutical design viz. liposome, nanotubes, polymer lipid hybrid system, which focuses to make the chemotherapy curative and long-lasting. In this review, we aimed to discuss the recent advancement of different surface-engineered/targeted nanomedicines that improved the drug efficacy in breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Kwon, G. S. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i5.20 · Cited by 502
Liu, L., Wang, Y., Miao, L., Liu, Q., Musetti, S., Li, J., & Huang, L. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.10.020 · Cited by 373
Hybrid nanoparticles for combination therapy of cancer
He, C., Lu, J., & Lin, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.029 · Cited by 174
Research works printed but not linked: 179
- Siersbak, 2018, Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer, Genes Dev., 32, 1141, 10.1101/gad.316646.118 · DOI
- Kohler, 2015, Annual report to the nation on the status of cancer, 1975– 2011, featuring incidence of breast cancer subtypes by race/ ethnicity, poverty, and state, J. Natl. Cancer Inst., 107, 10.1093/jnci/djv048 · DOI · Paper page
- Golubnitschaja, 2016, Breast cancer epidemic in the early 21st century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures, J. Immunother. Emphasis Tumor Immunol., 37, 12941
- Youn, 2018, Perspectives on the past, present, and future of cancer nanomedicine, Adv. Drug Deliv. Rev., 130, 3, 10.1016/j.addr.2018.05.008 · DOI · Paper page
- El-Sawy, 2018, Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives, ACS Nano, 12, 10636, 10.1021/acsnano.8b06104 · DOI · Paper page
- Ma, 2019, Atorvastatin inhibits breast Cancer cells by downregulating PTEN/AKT pathway via PromotingRas homolog family member B (RhoB), Biomed Res. Int., 2019, 10.1155/2019/3235021 · DOI
- Barron, 2008, Assessing the economic burden of breast cancer in a US managed care population, Breast Cancer Res. Treat., 109, 367, 10.1007/s10549-007-9650-4 · doi:10.1007/s10549-007-9650-4
- Zucchetti, 2019, The role of histone deacetylase inhibitors in metastatic breast cancer, Breast., 43, 130, 10.1016/j.breast.2018.12.001 · DOI
- Daniel, 2016, Recent advances in the medical treatment of breast cancer, Version F1000Res., 5, 2786, 10.12688/f1000research.9619.1 · DOI
- D. Mei, B. Chen, B. He, H. Liu, Z. Lin, J. Lin, X. Zhang, N. Sun, L. Zhao, X. Wang, Q. Zhang, Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2019.03.006. · DOI
- Hare, 2017, Challenges and strategies in anti-cancer nanomedicine development: an industry perspective, Adv. Drug Deliv. Rev., 108, 25, 10.1016/j.addr.2016.04.025 · DOI · Paper page
- Sang, 2018, Multifunctional hyaluronic acid-decorated redox-responsive magnetic complex micelle for targeted drug delivery with enhanced antitumor efficiency and anti-cell-Migration activity, J. Biomed. Nanotechnol., 14, 477, 10.1166/jbn.2018.2541 · DOI
- Peng, 2019, Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness, Nat. Nanotechnol., 14, 279, 10.1038/s41565-018-0356-z · DOI · Paper page
- Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat. Rev. Cancer, 17, 20, 10.1038/nrc.2016.108 · DOI · Paper page
- Xie, 2019, Challenges and opportunities from basic Cancer biology for nanomedicine for targeted drug delivery, Curr. Cancer Drug Targets, 19, 257, 10.2174/1568009618666180628160211 · DOI
- Avitabile, 2018, How can nanotechnology help the fight against breast cancer?, Nanoscale, 10, 11719, 10.1039/C8NR02796J · DOI
- Mahmoodzadeh, 2018, A novel gold-based stimuli-responsive theranostic nanomedicine for chemo-photothermal therapy of solid tumors, Mater. Sci. Eng. C Mater. Biol. Appl., 93, 880, 10.1016/j.msec.2018.08.067 · DOI
- Juneja, 2019, Multimodal polysilsesquioxane nanoparticles for combinatorial therapy and gene delivery in triple-negative breast Cancer, ACS Appl. Mater. Interfaces, 11, 12308, 10.1021/acsami.9b00704 · DOI · Paper page
- Matsumura, 1986, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res., 46, 6387
- Gerlowski, 1986, Microvascular permeability of normal and neoplastic tissues, Microvasc. Res., 31, 288, 10.1016/0026-2862(86)90018-X · DOI · Paper page
- Sang, 2018, A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer, Drug Deliv., 25, 1846, 10.1080/10717544.2018.1486472 · DOI
- Weiss, 2013, First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies Investig, New Drugs., 31, 986, 10.1007/s10637-012-9921-8 · DOI · Paper page
- Ashton, 2016, Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo, Sci. Transl. Med., 8, 10.1126/scitranslmed.aad2355 · DOI · Paper page
- Allahverdiyev, 2018, Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects, Artif. Cells Nanomed. Biotechnol., 46, S755, 10.1080/21691401.2018.1511573 · DOI · Paper page
- Akhter, 2018, Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics, Artif. Cells Nanomed. Biotechnol., 46, 873, 10.1080/21691401.2017.1366333 · DOI
- Yi, 2019, Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells, J. Control. Release, 295, 268, 10.1016/j.jconrel.2019.01.006 · DOI · Paper page
- Adil. Allahverdiyev, 2018, Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects, Artif. Cells Nanomed. Biotechnol., 46, S755, 10.1080/21691401.2018.1511573 · DOI · Paper page
- Yewale, 2018, Docetaxel loaded immunonanoparticles delivery in EGFR over expressed breast carcinoma cells, J. Drug Deliv. Sci. Technol., 45, 334, 10.1016/j.jddst.2018.03.027 · DOI
- Sneider, 2017, Engineering remotely triggered liposomes to target triple negative breast cancer, Oncomedicine., 2, 1, 10.7150/oncm.17406 · DOI
- Pillai, 2019, Applications of targeted nano drugs and delivery systems. Chapter 9 - nanotechnology toward treating cancer: a comprehensive review, 221
- Cao, 2019, Direct nucleus-targeted drug delivery using cascade pHe /Photo dual-sensitive polymeric nanocarrier for Cancer therapy, Small., 18
- Zhou, 2019, Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer, Biomaterials., 195, 86, 10.1016/j.biomaterials.2019.01.007 · DOI
- Liu, 2018, Targeting 17q23 amplicon to overcome the resistance to anti HER2 therapy in HER2+ breast cancer, Nat. Commun., 9, 4718, 10.1038/s41467-018-07264-0 · DOI
- Zheng, 2019, Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo, Biomed. Pharmacother., 116, 10.1016/j.biopha.2019.109006 · DOI · Paper page
- Legut, 2014, Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines - in vitro studies, Int. J. Nanomedicine, 9, 653
- Yingchoncharoen, 2016, Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come, Pharmacol. Rev., 68, 701, 10.1124/pr.115.012070 · DOI · Paper page
- Vail, 2004, Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies, Semin. Oncol., 31, 16, 10.1053/j.seminoncol.2004.08.002 · DOI · Paper page
- Zhao, 2019, Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: synthesis and biological evaluation, Chem. Phys. Lipids, 223, 10.1016/j.chemphyslip.2019.104785 · DOI
- Samson, 2019, Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU, J. Liposome Res., 29, 44, 10.1080/08982104.2017.1420081 · DOI
- Jiang, 2018, Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin, J. Control. Release, 271, 21, 10.1016/j.jconrel.2017.12.026 · DOI
- Mrugala, 2019, Phase II study of systemic high-dose methotrexate and intrathecal liposomal cytarabine for treatment of leptomeningeal carcinomatosis from breast Cancer, Clin. Breast Cancer, 18
- Schneeweiss, 2019, Eur. J. Cancer, 106, 181, 10.1016/j.ejca.2018.10.015 · DOI
- Xia, 2018, Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer, Pharm. Dev. Technol., 23, 13, 10.1080/10837450.2016.1265553 · DOI
- Cai, 2011, Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles, Adv. Drug Deliv. Rev., 63, 901, 10.1016/j.addr.2011.05.017 · DOI · Paper page
- Siram, 2014, Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation, Expert Opin. Drug Deliv., 11, 1351, 10.1517/17425247.2014.915310 · DOI
- Jain, 2019, Beta-carotene-Encapsulated solid lipid nanoparticles (BC-SLNs) as promising vehicle for Cancer: an investigative assessment, AAPS PharmSciTech, 20, 100, 10.1208/s12249-019-1301-7 · DOI
- Xu, 2018, Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells, Int. J. Nanomedicine, 13, 7549, 10.2147/IJN.S182621 · DOI
- Siddhartha, 2018, RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies, Artif. Cells Nanomed. Biotechnol., 46, 387, 10.1080/21691401.2017.1313267 · DOI
- Zhang, 2019, Biodegradable hybrid mesoporous silica nanoparticles for gene/chemo-synergetic therapy of breast cancer, J. Biomater. Appl., 33, 1382, 10.1177/0885328219835490 · DOI
- Eskiler, 2018, Solid lipid nanoparticles: reversal of tamoxifen resistance in breast cancer, Eur. J. Pharm. Sci., 120, 73, 10.1016/j.ejps.2018.04.040 · DOI
- Jadon, 2019, Docetaxel-loaded lipid-polymer hybrid nanoparticles for breast cancer therapeutics, J. Drug Deliv. Sci. Technol., 51, 475, 10.1016/j.jddst.2019.03.039 · DOI
- Varshosaz, 2018, Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells, J. Liposome Res., 28, 285, 10.1080/08982104.2017.1370471 · DOI
- Agrawal, 2018, CD44 targeting hyaluronic acid coated lapatinib nanocrystals foster the efficacy against triple-negative breast cancer, Nanomedicine, 14, 327, 10.1016/j.nano.2017.10.010 · DOI
- Chen, 2019, Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer, Colloids Surf B Biointerfaces, 177, 294, 10.1016/j.colsurfb.2019.02.001 · DOI
- Du, 2019, Polymer-lipid hybrid nanoparticles: a novel drug delivery system for enhancing the activity of Psoralen against breast cancer, Int. J. Pharm., 561, 274, 10.1016/j.ijpharm.2019.03.006 · DOI
- Soe, 2019, Transferrin-conjugated polymeric nanoparticle for receptor-mediated delivery of doxorubicin in doxorubicin-resistant breast Cancer cells, Pharmaceutics., 11, 10.3390/pharmaceutics11020063 · DOI
- Yuan, 2018, pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer, Artif. Cells Nanomed. Biotechnol., 46, 302, 10.1080/21691401.2017.1423495 · DOI
- Hu, 2018, Redox-sensitive folate-conjugated polymeric nanoparticles for combined chemotherapy and photothermal therapy against breast Cancer, J. Biomed. Nanotechnol., 14, 2018, 10.1166/jbn.2018.2647 · DOI
- Chandra, 2014, Advances in preparation and characterization of chitosan nanoparticles for therapeutics, Artif. Cells Nanomed. Biotechnol., 44, 305, 10.3109/21691401.2014.948548 · DOI
- Ebrahimi, 2016, Novel drug delivery system based on doxorubicin encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer, Artif. Cells Nanomed. Biotechnol., 44, 290, 10.3109/21691401.2014.944646 · DOI
- Niu, 2019, A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy, Chem. Eng. J., 369, 134, 10.1016/j.cej.2019.02.201 · DOI
- Abou-El-Naga, 2018, Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells, Int. J. Nanomedicine, 13, 8153, 10.2147/IJN.S182184 · DOI
- DeVeaux, 2019, Assessing the potential of Chitosan/Polylactide nanoparticles for delivery of therapeutics for triple-negative breast Cancer treatment, Regen. Eng. Transl. Med., 5, 61, 10.1007/s40883-018-0089-4 · DOI
- Bressler, 2018, Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells, J. Biomed. Mater. Res. Part B Appl. Biomater., 106A, 1753, 10.1002/jbm.a.36360 · DOI
- Nosrati, 2018, PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells, Drug Dev. Ind. Pharm., 44, 1377, 10.1080/03639045.2018.1451881 · DOI
- Nicolas, 2018, Polymeric nanocapsules as drug carriers for sustained anticancer activity of calcitriol in breast cancer cells, Int. J. Pharm., 550, 170, 10.1016/j.ijpharm.2018.08.022 · DOI
- Enteshari, 2018, Antitumor activity of raloxifene-targeted poly (styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice, Invest. New Drugs, 36, 206, 10.1007/s10637-017-0533-1 · DOI
- Yang, 2018, A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications, Acta Biomater., 79, 306, 10.1016/j.actbio.2018.08.036 · DOI
- Kutlehria, 2018, Cholecalciferol-PEG conjugate based nanomicelles of doxorubicin for treatment of triple-negative breast Cancer, AAPS PharmSciTech, 19, 792, 10.1208/s12249-017-0885-z · DOI
- Baidya, 2019, Chrysin-loaded folate conjugated PF127-F68 mixed micelles with enhanced oral bioavailability and anticancer activity against human breast cancer cells, Drug Dev. Ind. Pharm., 45, 852, 10.1080/03639045.2019.1576726 · DOI
- Pawar, 2019, Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting, Artif Cells Nanomed Biotechnol, 46 sup1, 347
- Farrokhi, 2018, Delivery of DNAzyme targeting c-Myc gene using β-cyclodextrin polymer nanocarrier for therapeutic application in human breast cancer cell line, J. Drug Deliv. Sci. Technol., 47, 477, 10.1016/j.jddst.2018.08.015 · DOI
- Rodriguez-Razon, 2018, Adhesion, proliferation, and apoptosis in different molecular portraits of breast cancer treated with silver nanoparticles and its pathway-network analysis, Int. J. Nanomedicine, 13, 1081, 10.2147/IJN.S152237 · DOI
- Gurunathan, 2015, Comparative assessment of the apoptotic potential of silver nanoparticles synthesized by Bacillus tequilensis and Calocybe indica in MDA-MB-231 human breast cancer cells: targeting p53 for anticancer therapy, Int. J. Nanomed., 10, 4203, 10.2147/IJN.S83953 · DOI · Paper page
- Jin, 2018, Theranostics of triple-negative breast Cancer Based on conjugated polymer nanoparticles, ACS Appl. Mater. Interfaces, 10, 10634, 10.1021/acsami.7b14603 · DOI
- Garcia, 2018, Targeted photodynamic therapy of breast cancer cells using lactose-phthalocyanine functionalized gold nanoparticles, J. Colloid Interface Sci., 512, 249, 10.1016/j.jcis.2017.10.030 · DOI
- Chowdhury, 2019, Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells, J. Colloid Interface Sci., 535, 133, 10.1016/j.jcis.2018.09.072 · DOI · Paper page
- Kamaruzman, 2019, Oncogenic signaling in Tumorigenesis and applications of siRNA nanotherapeutics in breast Cancer, Cancers (Basel)., 11, 10.3390/cancers11050632 · DOI
- Nunez, 2018, Inorganic nanoparticles in diagnosis and treatment of breast cancer, J. Biol. Inorg. Chem., 23, 331, 10.1007/s00775-018-1542-z · DOI
- Mahendran, 2018, Coumarin–gold nanoparticle bioconjugates: preparation, antioxidant, and cytotoxic effects against MCF-7 breast cancer cells, Appl. Nanosci., 8, 447, 10.1007/s13204-018-0816-7 · doi:10.1007/s13204-018-0816-7
- Nosrati, 2017, Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells, Drug Dev. Ind. Pharm., 27, 1
- Nosrati, 2018, Anticancer activity of tamoxifen loaded tyrosine decorated biocompatible Fe3O4 magnetic nanoparticles against breast Cancer cell lines, JIOPM., 28, 1178
- Manatunga, 2018, Effective delivery of hydrophobic drugs to breast and liver cancer cells using a hybrid inorganic nanocarrier: a detailed investigation using cytotoxicity assays, fluorescence imaging and flow cytometry, Eur. J. Pharm. Biopharm., 128, 18, 10.1016/j.ejpb.2018.04.001 · DOI
- Jin, 2019, Near-infrared light-regulated cancer theranostic nanoplatform based on aggregation-induced emission luminogen encapsulated upconversion nanoparticles, Theranostics., 9, 246, 10.7150/thno.30174 · DOI
- Sinha, 2005, Carbon nanotubes for biomedical applications, IEEE Trans Nanobiosci., 4, 180, 10.1109/TNB.2005.850478 · DOI · Paper page
- Fabbro, 2012, Targeting carbon nanotubes against cancer, Chem. Commun. (Camb.), 48, 3911, 10.1039/c2cc17995d · DOI · Paper page
- Liu, 2019, Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer, Pharmazie., 74, 83
- Moreira, 2016, Stimuli-responsive mesoporous silica nanoparticles for cancer therapy: a review, Microporous Mesoporous Mater., 236, 141, 10.1016/j.micromeso.2016.08.038 · DOI · Paper page
- Feng, 2016, The application of mesoporous silica nanoparticle family in cancer theranostics, Coord. Chem. Rev., 319, 86, 10.1016/j.ccr.2016.04.019 · DOI · Paper page
- Zhou, 2018, Mesoporous silica nanoparticles for drug and gene delivery, Acta Pharm. Sin. B, 8, 165, 10.1016/j.apsb.2018.01.007 · DOI · Paper page
- Freitas, 2017, Multifunctional mesoporous silica nanoparticles for cancer-targeted, controlled drug delivery and imaging, Microporous Mesoporous Mater., 242, 271, 10.1016/j.micromeso.2017.01.036 · DOI
- Wang, 2018, Stimuli-responsive nanocarrier for Co-delivery of MiR-31 and doxorubicin to suppress high MtEF4 Cancer, ACS Appl. Mater. Interfaces, 10, 22767, 10.1021/acsami.8b07698 · DOI
- Li, 2018, Actively Targeted Deep Tissue Imaging and Photothermal-Chemo Therapy of Breast Cancer by Antibody-Functionalized Drug-Loaded X-Ray-Responsive Bismuth Sulfide@Mesoporous Silica Core-Shell Nanoparticles, Adv. Funct. Mater., 28
- Zayed, 2019, Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging, Nanomedicine Lond. (Lond), 14, 225, 10.2217/nnm-2018-0414 · doi:10.2217/nnm-2018-0414
- Kefayat, 2019, Investigation of different targeting decorations effect on the radiosensitizing efficacy of albumin-stabilized gold nanoparticles for breast cancer radiation therapy, Eur. J. Pharm. Sci., 130, 225, 10.1016/j.ejps.2019.01.037 · DOI · Paper page
- Dalmina Pittella F, 2019, Magnetically responsive hybrid nanoparticles for in vitro siRNA delivery to breast cancer cells, Mater. Sci. Eng. C Mater. Biol. Appl., 99, 1182, 10.1016/j.msec.2019.02.026 · DOI
- Munster, 2018, Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study, Br. J. Cancer, 119, 1086, 10.1038/s41416-018-0235-2 · DOI · Paper page
- Jain, 2019, Dendrimer mediated targeting of siRNA against polo-like kinase for the treatment of triple negative breast cancer, J. Biomed. Mater. Res. A., 107, 1933, 10.1002/jbm.a.36701 · doi:10.1002/jbm.a.36701
- H. Qiao, Z. Zhu, D. Fang, Y. Sun, C. Kang, L. Di, L. Zhang, Y. Gao. Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breastcancer. J Drug Target. 26(1) 201875-201885. · DOI
- Xiong, 2018, Primary tumor and pre-metastatic niches co-targeting "peptides-lego" hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment, Biomater. Sci., 6, 2591, 10.1039/C8BM00706C · DOI
- Zhang, 2017, Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice, Acta Pharmacol. Sin., 38, 835, 10.1038/aps.2016.166 · DOI
- Kushwah, 2018, Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management, Acta Biomater., 73, 424, 10.1016/j.actbio.2018.03.057 · DOI
- Tang, 2018, Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands, Nanoscale, 10, 4258, 10.1039/C7NR08644J · DOI · Paper page
- Wu, 2019, A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy, J. Mater. Chem. B Mater. Biol. Med., 7, 477, 10.1039/C8TB02463D · DOI
- Vandghanooni, 2018, Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer, Eur. J. Pharm. Sci., 117, 301, 10.1016/j.ejps.2018.02.027 · DOI
- Ramirez-Garcia, 2018, An immuno -conjugated up-conversion nanocomplex for selective imaging and photodynamic therapy against HER2-positive breast cancer, Nanoscale., 10, 10154, 10.1039/C8NR01512K · DOI
- Pan, 2018, Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment, Int. J. Nanomedicine, 13, 1119, 10.2147/IJN.S147464 · DOI
- Liu, 2019, Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment, Acta Pharm. Sin. B, 9, 410, 10.1016/j.apsb.2018.09.001 · DOI · Paper page
- Barabadi, 2019, Emerging theranostic biogenic silver nanomaterials for breast Cancer: a systematic review, J. Clust. Sci., 30, 259, 10.1007/s10876-018-01491-7 · DOI
- Yao, 2016, Ligand-targeted theranostic nanomedicines against cancer, J. Control. Release, 240, 267, 10.1016/j.jconrel.2016.01.002 · DOI · Paper page
- Valizadeh, 2012, Quantum dots: synthesis, bioapplications, and toxicity, Nanoscale Res. Lett., 7, 480, 10.1186/1556-276X-7-480 · DOI · Paper page
- Volsi, 2018, Hybrid Gold/Silica/Quantum-dots supramolecular-nanostructures encapsulated in polymeric micelles as potential theranostic tool for targeted cancer therapy, Eur. Polym. J., 105, 38, 10.1016/j.eurpolymj.2018.05.013 · DOI
- Olerile, 2017, Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic, Colloids Surf. B Biointerfaces, 150, 121, 10.1016/j.colsurfb.2016.11.032 · DOI
- Yang, 2015, Facile synthesis of Gd-Cu-In-S/ZnS bimodal quantum dots with optimized properties for tumor targeted fluorescence/MR in vivo imaging, ACS Appl. Mater. Interfaces, 7, 18759, 10.1021/acsami.5b05372 · DOI
- Ghosh, 2019, Vol. 373, 468
- Kim, 2019, Anti-EGF receptor aptamer-guided Co-delivery of anti-cancer siRNAs and quantum dots for theranostics of triple-negative breast Cancer, Eranostics., 9, 837
- Liu, 2018, 2D superparamagnetic tantalum carbide composite MXenes for efficient breast-cancer theranostics, Theranostics., 8, 1648, 10.7150/thno.23369 · DOI · Paper page
- Zafar, 2019, Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems, Semin. Cancer Biol.
- Ahmadzada, 2018, Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer, Biophys. Rev., 10, 10.1007/s12551-017-0392-1 · DOI · Paper page
- Rahman, 2017, Therapeutic applications of liposomal based drug delivery and drug targeting for immune linked inflammatory maladies: a contemporary view point, Curr. Drug Targets, 18, 1558, 10.2174/1389450118666170414113926 · DOI
- Deng, 2014, Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer, Biomaterials, 35, 4333, 10.1016/j.biomaterials.2014.02.006 · DOI · Paper page
- Rahman, 2019, Vol. 26, 629
- Juneja, 2019, Multimodal polysilsesquioxane nanoparticles for combinatorial therapy and gene delivery in triple-negative breast Cancer, ACS Appl. Mater. Interfaces, 11, 12308, 10.1021/acsami.9b00704 · DOI · Paper page
- Pandey, 2018, Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin, Nanomedicine Lond. (Lond), 13, 849, 10.2217/nnm-2017-0306 · DOI
- Jafari, 2019, Anti-Mucin1 aptamer-conjugated chitosan nanoparticles for targeted Co-delivery of Docetaxel and IGF-1R siRNA to SKBR3 metastatic breast Cancer cells, Iran. Biomed. J., 23, 21, 10.29252/ibj.23.1.21 · DOI
- Beg, 2017, Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications, Drug Discov. Today, 22, 625, 10.1016/j.drudis.2016.10.001 · DOI · Paper page
- Cai, 2018, Enzyme-sensitive biodegradable and multifunctional polymeric conjugate as theranostic nanomedicine, Applied medicine today., 11, 207
- Rajendrakumar, 2018, Dual-stimuli-responsive albumin-polyplex nanoassembly for spatially controlled gene release in metastatic breast cancer, J. Control. Release, 276, 72, 10.1016/j.jconrel.2018.02.039 · DOI
- Karahaliloglu, 2018, Enhanced antitumor activity of epigallocatechin gallate– conjugated dual-drug-loaded polystyrene–polysoyaoil– diethanol amine nanoparticles for breast cancer therapy, J. Bioact. Compat. Polym., 33, 38, 10.1177/0883911517710811 · DOI
- Ghassami, 2019, HER-2 aptamer-targeted Ecoflex® nanoparticles loaded with docetaxel promote breast cancer cells apoptosis and anti-metastatic effect, IET Nanobiotechnol., 13, 428, 10.1049/iet-nbt.2018.5047 · DOI
- Wang, 2018, Indocyanine green-incorporating nanoparticles for cancer theranostics, Theranostics., 8, 1227, 10.7150/thno.22872 · DOI · Paper page
- Sang, 2018, Magnetic and CD44 receptor dual targeting redox-responsive polymeric micelle for precise delivery of Gambogic acid to triple-negative breast cancer, AJPS
- Zhang, 2019, Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer, Nano Res., 12, 855, 10.1007/s12274-019-2308-9 · DOI · Paper page
- Majidi N, 2018, Targeted Co-delivery of Docetaxel and cMET siRNA for treatment of Mucin1 overexpressing breast Cancer cells, Adv. Pharm. Bull., 8, 383, 10.15171/apb.2018.045 · DOI
- Ni, 2018, In situ shRNA synthesis on DNA-Polylactide nanoparticles to treat multidrug resistant breast Cancer, Adv Mater, 30
- Parhi, 2015, Trastuzumab guided nanotheranostics: a lipid based multifunctional nanoformulation for targeted drug delivery and imaging in breast cancer therapy, J. Colloid Interface Sci., 451, 198, 10.1016/j.jcis.2015.03.049 · DOI
- Truffi, 2018, Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells, Sci. Rep., 8, 6563, 10.1038/s41598-018-24968-x · DOI
- Bonizzi, 2019, Everolimus nanoformulation in biological nanoparticles increases drug responsiveness in resistant and low-responsive breast Cancer cell lines, Pharmaceutics., 11, E384, 10.3390/pharmaceutics11080384 · DOI
- Mazzucchelli, 2017, H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer, Sci. Rep., 7, 7505, 10.1038/s41598-017-07617-7 · DOI
- Dalmina, 2019, Magnetically responsive hybrid nanoparticles for in vitro siRNA delivery to breast cancer cells, Mater. Sci. Eng. C Mater. Biol. Appl., 99, 1182, 10.1016/j.msec.2019.02.026 · DOI
- Lee, 2019, Mitochondria targeting and destabilizing hyaluronic acid derivative-based nanoparticles for the delivery of lapatinib to triple-negative breast Cancer, Biomacromolecules., 20, 835, 10.1021/acs.biomac.8b01449 · DOI
- Zajdel, 2019, Cytotoxic effect of paclitaxel and lapatinib Co-delivered in polylactide-co-Poly(ethylene glycol) micelles on HER-2-Negative breast Cancer cells, Pharmaceutics., 11, E169, 10.3390/pharmaceutics11040169 · DOI
- Beg, 2019, Nanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccines, Semin. Cancer Biol.
- Kong, 2018, Polydopamine-functionalized CA-(PCL-ran-PLA) nanoparticles for target delivery of docetaxel and chemo-photothermal therapy of breast Cancer, Front. Pharmacol., 9, 125, 10.3389/fphar.2018.00125 · DOI
- Liu, 2019, Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment, Acta Pharm. Sin. B, 9, 410, 10.1016/j.apsb.2018.09.001 · DOI · Paper page
- Meng, 2019, Effect of chitosan based glycolipid-like nanocarrier in prevention of developing acquired drug resistance in tri-cycle treatment of breast cancer, Int J Pharma., 555, 303, 10.1016/j.ijpharm.2018.11.056 · DOI
- Li, 2018, α-Lipoic acid stabilized DTX/IR780 micelles for photoacoustic/fluorescence imaging guidedphotothermal therapy/chemotherapy of breast cancer, Biomater. Sci., 6, 1201, 10.1039/C8BM00096D · DOI
- Martínez-Jothar, 2019, Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination with Photochemical Internalization, J. Mol. Pharm. Org. Process Res., 16, 1633
- Wang, 2019, Sequentially self-assembled polysaccharide-based nanocomplexes for combined chemotherapy and photodynamic therapy of breast cancer, Carbohydr. Polym., 203, 203, 10.1016/j.carbpol.2018.09.035 · DOI
- Aneja, 2014, Cancer targeted magic bullets for effective treatment of cancer, Recent Pat. Antiinfect. Drug Discov., 9, 121, 10.2174/1574891X10666150415120506 · DOI · Paper page
- Liu, 2018, Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy, Acta Biomater., 66, 310, 10.1016/j.actbio.2017.11.010 · DOI · Paper page
- Guney Eskiler, 2018, Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer, Eur. J. Pharm. Sci., 120, 73, 10.1016/j.ejps.2018.04.040 · DOI
- Rahman, 2016, Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art, Artif. Cells Nanomed. Biotechnol., 44, 1597, 10.3109/21691401.2015.1129617 · DOI
- Souto, 2019, Surface-tailored anti-HER2/neu-solid lipid nanoparticles for site-specific targeting MCF-7 and BT-474 breast cancer cells, Eur. J. Pharm. Sci., 128, 27, 10.1016/j.ejps.2018.11.022 · DOI
- Zheng, 2019, Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo, Biomed. Pharmacother., 116, 10.1016/j.biopha.2019.109006 · DOI · Paper page
- Yang, 2018, A cancer cell turn-on protein-CuSMn nanoparticle as the sensor of breast cancer cell and CH3O-PEG-phosphatide, Chinese Chem. Lett., 29, 1528, 10.1016/j.cclet.2018.02.011 · doi:10.1016/j.cclet.2018.02.011
- Kefayat, 2019, Investigation of different targeting decorations effect on the radiosensitizing efficacy of albumin-stabilized gold nanoparticles for breast cancer radiation therapy, Eur. J. Pharm. Sci., 130, 225, 10.1016/j.ejps.2019.01.037 · DOI · Paper page
- Rezaei, 2018, NanoMIL-100(Fe) containing docetaxel for breast cancer therapy, Artif. Cells Nanomed. Biotechnol., 46, 1390, 10.1080/21691401.2017.1369425 · DOI
- García Calavia, 2018, Targeted photodynamic therapy of breast cancer cells using lactose-phthalocyanine functionalized gold nanoparticles, J. Colloid Interface Sci., 512, 249, 10.1016/j.jcis.2017.10.030 · DOI
- Hou, 2019, A novel pH-sensitive targeting polysaccharide-gold nanorod conjugate for combined photothermal-chemotherapy of breast cancer, Carbohydr. Polym., 212, 334, 10.1016/j.carbpol.2019.02.045 · DOI
- Graham-Gurysh, 2018, Hybrid donor-acceptor polymer particles with amplified energy transfer for detection and on-demand treatment of breast Cancer, ACS Appl. Mater. Interfaces, 10, 7697, 10.1021/acsami.7b19503 · DOI
- Ahmad, 2014, Transformation of curcumin from food additive to multifunctional medicine: nanotechnology bridging the gap, Curr. Drug Discov. Technol., 11, 197, 10.2174/1570163811666140616153436 · DOI
- Baneshi, 2019, A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery, Int. J. Pharm., 564, 145, 10.1016/j.ijpharm.2019.04.025 · DOI
- Akhter, 2011, Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern, Curr. Pharm. Des., 17, 1834, 10.2174/138161211796391001 · DOI
- Zhan, 2019, DNA-based nanomedicine with targeting and enhancement of therapeutic efficacy of breast Cancer cells, ACS Appl. Mater. Interfaces, 11, 15354, 10.1021/acsami.9b03449 · DOI
- Nguyen, 2019, Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo, Colloids Surf. B Biointerfaces, 173, 539, 10.1016/j.colsurfb.2018.10.013 · DOI
- Yi, 2019, Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells, J. Control. Release, 295, 268, 10.1016/j.jconrel.2019.01.006 · DOI · Paper page
- Rizwanullah, 2019, Polymer-lipid hybrid systems: scope of intravenous-to-Oral switch in Cancer chemotherapy, Curr. Nanomed., 9, 1
- Talamantez-Lyburn, 2019, Gold nanoparticles loaded with cullin-5 DNA increase sensitivity to 17-AAG in cullin-5 deficient breast cancer cells, Int. J. Pharm., 564, 281, 10.1016/j.ijpharm.2019.04.022 · DOI
- Gajendiran, 2019, Green synthesis of multifunctional PEG-carboxylate π back-bonded gold nanoconjugates for breast cancer treatment, Int. J. Nanomedicine, 14, 819, 10.2147/IJN.S190946 · DOI
- Vinothini, 2019, Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarriers, Biomed. Pharmacother., 110, 906, 10.1016/j.biopha.2018.12.008 · DOI
- Ahmad, 2010, Metallic nanoparticles: technology overview & drug delivery applications in oncology, Expert Opin. Drug Deliv., 7, 927, 10.1517/17425247.2010.498473 · DOI · Paper page
- Yu, 2018, Antitumor effects of carbon nanotube-drug complex against human breast cancer cells, Exp. Ther. Med., 16, 1103, 10.3892/etm.2016.3444 · DOI
- A. Oskoueian, K. A. Matori,S. Bayat, E. Oskoueian, F. Ostovan, M. Toozandehjani, Fabrication, Characterization, and Functionalization of Single-Walled Carbon Nanotube Conjugated with Tamoxifen and Its Anticancer Potential against Human Breast Cancer Cells, Journal of Nanomaterials. doi.org/10.1155/2018/8417016. · DOI
- Vemuri, 2019, Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: Synthesis, biological evaluation, molecular modelling studies, Mater. Sci. Eng. C Mater. Biol. Appl., 99, 417, 10.1016/j.msec.2019.01.123 · doi:10.1016/j.msec.2019.01.123
- Yuan, 2018, pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer, Artif. Cells Nanomed. Biotechnol., 46, 302, 10.1080/21691401.2017.1423495 · DOI
- Abedin, 2018, Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications, J. Nanobiotechnology, 16, 80, 10.1186/s12951-018-0405-7 · DOI
- Beg, 2018, In: chapter 4 - emergence in the functionalized carbon nanotubes as smart nanocarriers for drug delivery applications, 105
- Du, 2019, Polymer-lipid hybrid nanoparticles: A novel drug delivery system for enhancing the activity of Psoralen against breast cancer, Int. J. Pharm., 561, 274, 10.1016/j.ijpharm.2019.03.006 · DOI
Cited by
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Lu, H., Zhang, S., Wang, J., & Chen, Q. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.783831 · Cited by 334
Nanoparticles in Clinical Translation for Cancer Therapy
Mundekkad, D., & Cho, W. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031685 · Cited by 305
Chitosan-Based Nanoparticles of Targeted Drug Delivery System in Breast Cancer Treatment
Herdiana, Y., Wathoni, N., Shamsuddin, S., Joni, I. M., & Muchtaridi, M. (2021) · Polymers · doi:10.3390/polym13111717 · Cited by 196
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
“Equipping nanotechnology with existing cancer therapies to enhance drug efficiency and limit its systematic toxicity, known as cancer nanotechnology.(140) Nanocarriers for cancer treatment are aimed to deliver the loaded-molecules to and around the targeted pathologic tissue, killing cancer cells without harming the n…”
Background
Metadata
- Authors
- Afzal, M., Ameeduzzafar, Alharbi, K. S., Alruwaili, N. K., Al-Abassi, F. A., Al-Malki, A. A. L., Kazmi, I., Kumar, V., Kamal, M. A., Nadeem, M. S., Aslam, M., & Anwar, F.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 69
- Pages
- 279-292
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2995027661
- Cited by
- 123
- References
- 7
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanomedicine in treatment of breast cancer – A challenge to conventional therapy. https://app.cochat.ai/papers/10.1016/j.semcancer.2019.12.016
- The paper
- Afzal, M., Ameeduzzafar, Alharbi, K. S., Alruwaili, N. K., Al-Abassi, F. A., Al-Malki, A. A. L., Kazmi, I., Kumar, V., Kamal, M. A., Nadeem, M. S., Aslam, M., & Anwar, F. (2021). Nanomedicine in treatment of breast cancer – A challenge to conventional therapy. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2019.12.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.